⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BEAM News
Beam Therapeutics Inc. Common Stock
Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight
globenewswire.com
BDX
DHR
ABT
QDEL
FLUX
TMO
DGX
ILMN
EXAS
BIO
BIIB
GILD
AMGN
MRK
PACB
CRSP
EDIT
BEAM
BEAM Unveils Five Breakthrough Technologies That Redefine the Future of Livestreaming
accessnewswire.com
BEAM
WHERE CRAFT MEETS CREATIVITY: JAMES B. BEAM DISTILLING CO. LAUNCHES CREATOR CAMPUS
prnewswire.com
BEAM
STZ
Form 8-K
sec.gov
BEAM
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
globenewswire.com
BEAM
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
globenewswire.com
BEAM
Generative AI in HR Market Set to Hit $1.7 Billion by 2030 with 17.8% CAGR Growth
globenewswire.com
IBM
ORCL
SAP
ADP
WDAY
BEAM
HORNITOS® TEQUILA AND JARRITOS® LAUNCH THE SERVE OF THE SUMMER WITH NEW LIMITED-EDITION MARGARITOS VARIETY PACK
prnewswire.com
BEAM
Gene Editing Therapeutics: Transforming Biopharmaceuticals with 12.5% CAGR Growth Forecast
globenewswire.com
CRSP
NTLA
EDIT
BEAM
SANG
CELC
CRBU
PRME
Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration
globenewswire.com
BEAM